A small UK company has presented positive results from a Phase II trial investigating the use of bacteriophages for the treatment of Pseudomonas infections. The product, while still in the early stages of clinical development, represents a novel approach to the treatment of bacterial infections and offers a crucial new avenue of research in the treatment of Pseudomonas.
Edit my basket
© Datamonitor 2014. All rights reserved
Terms & Conditions